These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 10363966

  • 1. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells.
    Grooteclaes M, Vernimmen D, Plaza S, Pasleau F, Hodzic D, Winkler-Gol R.
    Cancer Res; 1999 Jun 01; 59(11):2527-31. PubMed ID: 10363966
    [Abstract] [Full Text] [Related]

  • 2. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.
    Vernimmen D, Begon D, Salvador C, Gofflot S, Grooteclaes M, Winkler R.
    Biochem J; 2003 Feb 15; 370(Pt 1):323-9. PubMed ID: 12418962
    [Abstract] [Full Text] [Related]

  • 3. Expression of HER2 and its association with AP-2 in breast cancer.
    Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J, Eskelinen M, Kosma VM.
    Eur J Cancer; 2004 Jul 15; 40(10):1485-95. PubMed ID: 15196531
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells.
    Dong Y, Asch HL, Ying A, Asch BB.
    Exp Cell Res; 2002 Jun 10; 276(2):328-36. PubMed ID: 12027462
    [Abstract] [Full Text] [Related]

  • 5. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
    Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, Chew K, Ljung BM, Edgerton S, Thor A, Hassell JA.
    Oncogene; 1997 Sep 25; 15(13):1513-25. PubMed ID: 9380403
    [Abstract] [Full Text] [Related]

  • 6. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL, Miron A, Andersen LM, Iglehart JD, Marks JR.
    Oncogene; 1999 Oct 28; 18(44):6000-12. PubMed ID: 10557089
    [Abstract] [Full Text] [Related]

  • 7. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
    Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F.
    Oncogene; 2001 Apr 19; 20(17):2101-11. PubMed ID: 11360194
    [Abstract] [Full Text] [Related]

  • 8. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
    Newman SP, Bates NP, Vernimmen D, Parker MG, Hurst HC.
    Oncogene; 2000 Jan 27; 19(4):490-7. PubMed ID: 10698518
    [Abstract] [Full Text] [Related]

  • 9. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C, Zhou Y, Zhou Z, Sun X, Otto KB, Uht RM, Dong JT.
    Gene; 2004 Apr 14; 330():133-42. PubMed ID: 15087132
    [Abstract] [Full Text] [Related]

  • 10. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
    Manfroid I, Van de Weerdt C, Baudhuin A, Martial JA, Muller M.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):127-39. PubMed ID: 15607537
    [Abstract] [Full Text] [Related]

  • 11. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 12. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu.
    Roh H, Pippin J, Boswell C, Drebin JA.
    J Surg Res; 1998 Jun 15; 77(1):85-90. PubMed ID: 9698539
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.
    De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B, Di Renzo MF.
    Cancer Res; 2005 Feb 01; 65(3):907-12. PubMed ID: 15705889
    [Abstract] [Full Text] [Related]

  • 14. A novel cis-acting element in Her2 promoter regulated by Stat3 in mammary cancer cells.
    Qian L, Chen L, Shi M, Yu M, Jin B, Hu M, Xia Q, Zhang X, Shen B, Guo N.
    Biochem Biophys Res Commun; 2006 Jun 30; 345(2):660-8. PubMed ID: 16696944
    [Abstract] [Full Text] [Related]

  • 15. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK, Iglehart JD.
    J Cell Physiol; 2006 Dec 30; 209(3):645-52. PubMed ID: 17001676
    [Abstract] [Full Text] [Related]

  • 16. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
    Niu G, Carter WB.
    Cancer Res; 2007 Feb 15; 67(4):1487-93. PubMed ID: 17308086
    [Abstract] [Full Text] [Related]

  • 17. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G, Zhu B, Rosa F, Deblon N, Adélaïde J, Kahn-Perlès B, Birnbaum D, Imbert J.
    Mol Cancer Res; 2009 Mar 15; 7(3):402-14. PubMed ID: 19276186
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines.
    Skinner A, Hurst HC.
    Oncogene; 1993 Dec 15; 8(12):3393-401. PubMed ID: 8247542
    [Abstract] [Full Text] [Related]

  • 19. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T.
    Biochem J; 2003 Oct 01; 375(Pt 1):199-205. PubMed ID: 12841847
    [Abstract] [Full Text] [Related]

  • 20. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
    Lambertini E, Penolazzi L, Giordano S, Del Senno L, Piva R.
    Biochem J; 2003 Jun 15; 372(Pt 3):831-9. PubMed ID: 12659635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.